雅虎香港 搜尋

搜尋結果

  1. 正選
    後備
    入球
    黃牌
    紅牌
    上陣
    賽季 202333
    10
    4
    5
    0
    43
    西班牙足球甲級聯賽1:00 下午 EDT
    8月 19日@華拉度列
    西班牙足球甲級聯賽3:30 下午 EDT
    8月 24日vs皇家蘇斯達
  2. Eisai Announces Appointments of Directors and Corporate Officers. Eisai Co., Ltd. announced that the following Directors and Corporate Officers for FY2024 were appointed by resolutions at the 112th Ordinary General Meeting of Shareholders and subsequent Board of Directors meeting held today. Directors (*Outside Directors) Board of Directors.

  3. 2021年7月2日 · Eisai has been supporting the Pacific Program to Eliminate Lymphatic Filariasis (PacELF) of World Health Organization (WHO) in collaboration with Japan International Cooperation Agency (JICA) since 2013. Eisai has provided approximately 10.4 million DEC tablets, a treatment for lymphatic filariasis, to Papua New Guinea.

  4. January 7, 2023. Eisai Co., Ltd. EISAI’S APPROACH TO U.S. PRICING FOR LEQEMBITM (LECANEMAB), A TREATMENT FOR EARLY ALZHEIMER’S DISEASE, SETS FORTH OUR CONCEPT OF “SOCIETAL VALUE OF MEDICINE” IN RELATION TO “PRICE OF MEDICINE” MAXIMIZING VALUE FOR ALL STAKEHOLDERS WHILE GIVING BACK VALUE TO SOCIETY .

  5. www.eisai.com › news › 2024No.24-49

    AHEAD 3-45 is conducted as a public-private partnership between the Alzheimer's Clinical Trial Consortium that provides the infrastructure for academic clinical trials in AD and related dementias in the U.S, funded by the National Institute on Aging, part of the National Institutes of Health, Eisai and Biogen.

  6. Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today the presentation of research across multiple types of cancer from its oncology portfolio and pipeline during the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (#ASCO24), which is taking place virtually and in-person in Chicago, Illinois from May 3...

  7. Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today the presentation of oncology research at two upcoming medical meetings taking place in-person in San Francisco, California and virtually.

  8. Brepacise is a dual-task exercise program that stimulates the body and brain by moving the arms and legs to music while also incorporating intellectual challenges. Eisai developed this product with the review of a physician as an easy and fun introductory exercise for those concerned about their brain health.